Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions

Schizophrenia, which affects around 1% of the world’s population, has been described as a complex set of symptoms triggered by multiple factors. However, the exact background mechanisms remain to be explored, whereas therapeutic agents with excellent effectivity and safety profiles have yet to be de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Molecules
Main Authors: Zádor, Ferenc, Nagy-Grócz, Gábor, Kekesi, Gabriella, Dvorácskó, Szabolcs, Szűcs, Edina, Tömböly, Csaba, Horvath, Gyongyi, Benyhe, Sándor, Vécsei, László
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6832375/
https://ncbi.nlm.nih.gov/pubmed/31619006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24203709
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados